⌘K
Loading ticker…
ZOETIS INC. · Healthcare · Pharmaceutical Products
As of 2026-06-26, ZOETIS INC. (ZTS) has a 3-month relative strength percentile of 9 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 35. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.1%, relative volume 2.22×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
9 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ZTS is in a stage 4 downtrend, week 10. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -15.5% / -36.0%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
ZTS is held by 21 ETFs as of Mar 2026. Top owner: VTI at 0.07% weight, $1.4B notional. Top 3 carry $3.7B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.07% | $1.4B |
| VOOVanguard S&P 500 ETF | 0.09% | $1.3B |
| VOVanguard Mid-Cap ETF | 0.49% | $970M |
| IVViShares Core S&P 500 ETF | 0.09% | $642M |
| SPYState Street SPDR S&P 500 ETF | 0.09% | $580M |
| XLVState Street Health Care Select Sector SPDR ETF | 0.94% | $363M |
| VOTVanguard Mid-Cap Growth ETF | 1.17% | $342M |
| VUGVanguard Growth ETF | 0.09% | $290M |
| VTVVanguard Value ETF | 0.09% | $208M |
| IWFiShares Russell 1000 Growth ETF | 0.15% | $168M |
Showing 10 of 21 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ZTS Jan avg: 3.04% median: 2.05% win: 50% σ: 7.70% n: 4 2022-04-12 → 2026-05-29 | ZTS Feb avg: 2.35% median: 2.97% win: 75% σ: 3.65% n: 4 2022-04-12 → 2026-05-29 | ZTS Mar avg: -6.60% median: -5.69% win: 0% σ: 6.84% n: 4 2022-04-12 → 2026-05-29 | ZTS Apr avg: -3.19% median: -5.01% win: 20% σ: 5.26% n: 5 2022-04-12 → 2026-05-29 | ZTS May avg: -5.79% median: -3.57% win: 40% σ: 16.22% n: 5 2022-04-12 → 2026-05-29 | ZTS Jun avg: 0.23% median: 1.40% win: 75% σ: 5.58% n: 4 2022-04-12 → 2026-05-29 (current) | ZTS Jul avg: 3.19% median: 5.03% win: 75% σ: 6.83% n: 4 2022-04-12 → 2026-05-29 | ZTS Aug avg: -0.94% median: 1.60% win: 75% σ: 9.27% n: 4 2022-04-12 → 2026-05-29 | ZTS Sep avg: -3.48% median: -5.85% win: 25% σ: 6.79% n: 4 2022-04-12 → 2026-05-29 | ZTS Oct avg: -4.52% median: -5.01% win: 25% σ: 5.50% n: 4 2022-04-12 → 2026-05-29 | ZTS Nov avg: 0.43% median: 0.13% win: 50% σ: 9.78% n: 4 2022-04-12 → 2026-05-29 | ZTS Dec avg: -0.52% median: -3.38% win: 25% σ: 8.43% n: 4 2022-04-12 → 2026-05-29 |